Leading Onychomycosis Treatment Country Markets Databank
The Onychomycosis Treatment market was valued at $4,200.0 Million in 2020, and is projected to reach $11,101.3 Million by 2029 growing at a CAGR of 11.47% from 2021 to 2029. North America is expected to be the highest contributor to this market, with $1,705.2 Million in 2020, and is anticipated to reach $4,045.6 Million by 2029, registering a CAGR of 10.11%. Asia-Pacific is anticipated to reach $3,197.4 Million by 2029 with the highest CAGR of 15.19%. North America and Europe collectively expected to account for about 71.0% share of the Onychomycosis Treatment market in 2020, with the former constituting around 40.6% share. Asia-Pacific and Europe are expected to witness significant growth rates at a CAGR of 15.19% and 10.87% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 51.8% in the overall Onychomycosis Treatment market in 2020, and is anticipated to reach 57.8% by 2029.
- 1. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET, BY REGION
- 1.1. OVERVIEW
- 1.2. NORTH AMERICA
- 1.2.1 NORTH AMERICA ONYCHOMYCOSIS TREATMENT MARKET, BY TREATMENT TYPE
- 1.2.2 NORTH AMERICA ONYCHOMYCOSIS TREATMENT MARKET, BY DRUG CLASS
- 1.2.3 NORTH AMERICA ONYCHOMYCOSIS TREATMENT MARKET, BY COUNTRY
- 1.2.3.1 U.S.
- 1.2.3.1.1 U.S. Onychomycosis Treatment Market, By Treatment type
- 1.2.3.1.2 U.S. Onychomycosis Treatment Market, By Drug Class
- 1.2.3.2 Canada
- 1.2.3.2.1 Canada Onychomycosis Treatment Market, By Treatment type
- 1.2.3.2.2 Canada Onychomycosis Treatment Market, By Drug Class
- 1.2.3.3 Mexico
- 1.2.3.3.1 Mexico Onychomycosis Treatment Market, By Treatment type
- 1.2.3.3.2 Mexico Onychomycosis Treatment Market, By Drug Class
- 1.3. EUROPE
- 1.3.1 EUROPE ONYCHOMYCOSIS TREATMENT MARKET, BY TREATMENT TYPE
- 1.3.2 EUROPE ONYCHOMYCOSIS TREATMENT MARKET, BY DRUG CLASS
- 1.3.3 EUROPE ONYCHOMYCOSIS TREATMENT MARKET, BY COUNTRY
- 1.3.3.1 Germany
- 1.3.3.1.1 Germany Onychomycosis Treatment Market, By Treatment type
- 1.3.3.1.2 Germany Onychomycosis Treatment Market, By Drug Class
- 1.3.3.2 France
- 1.3.3.2.1 France Onychomycosis Treatment Market, By Treatment type
- 1.3.3.2.2 France Onychomycosis Treatment Market, By Drug Class
- 1.3.3.3 UK
- 1.3.3.3.1 UK Onychomycosis Treatment Market, By Treatment type
- 1.3.3.3.2 UK Onychomycosis Treatment Market, By Drug Class
- 1.3.3.4 Italy
- 1.3.3.4.1 Italy Onychomycosis Treatment Market, By Treatment type
- 1.3.3.4.2 Italy Onychomycosis Treatment Market, By Drug Class
- 1.3.3.5 Spain
- 1.3.3.5.1 Spain Onychomycosis Treatment Market, By Treatment type
- 1.3.3.5.2 Spain Onychomycosis Treatment Market, By Drug Class
- 1.3.3.6 Russia
- 1.3.3.6.1 Russia Onychomycosis Treatment Market, By Treatment type
- 1.3.3.6.2 Russia Onychomycosis Treatment Market, By Drug Class
- 1.3.3.7 Rest of Europe
- 1.3.3.7.1 Rest of Europe Onychomycosis Treatment Market, By Treatment type
- 1.3.3.7.2 Rest of Europe Onychomycosis Treatment Market, By Drug Class
- 1.4. ASIA-PACIFIC
- 1.4.1 ASIA-PACIFIC ONYCHOMYCOSIS TREATMENT MARKET, BY TREATMENT TYPE
- 1.4.2 ASIA-PACIFIC ONYCHOMYCOSIS TREATMENT MARKET, BY DRUG CLASS
- 1.4.3 ASIA-PACIFIC ONYCHOMYCOSIS TREATMENT MARKET, BY COUNTRY
- 1.4.3.1 China
- 1.4.3.1.1 China Onychomycosis Treatment Market, By Treatment type
- 1.4.3.1.2 China Onychomycosis Treatment Market, By Drug Class
- 1.4.3.2 India
- 1.4.3.2.1 India Onychomycosis Treatment Market, By Treatment type
- 1.4.3.2.2 India Onychomycosis Treatment Market, By Drug Class
- 1.4.3.3 Japan
- 1.4.3.3.1 Japan Onychomycosis Treatment Market, By Treatment type
- 1.4.3.3.2 Japan Onychomycosis Treatment Market, By Drug Class
- 1.4.3.4 Australia
- 1.4.3.4.1 Australia Onychomycosis Treatment Market, By Treatment type
- 1.4.3.4.2 Australia Onychomycosis Treatment Market, By Drug Class
- 1.4.3.5 South Korea
- 1.4.3.5.1 South Korea Onychomycosis Treatment Market, By Treatment type
- 1.4.3.5.2 South Korea Onychomycosis Treatment Market, By Drug Class
- 1.4.3.6 Rest of Asia
- 1.4.3.6.1 Rest of Asia Onychomycosis Treatment Market, By Treatment type
- 1.4.3.6.2 Rest of Asia Onychomycosis Treatment Market, By Drug Class
- 1.5. REST OF WORLD
- 1.5.1 REST OF WORLD ONYCHOMYCOSIS TREATMENT MARKET, BY TREATMENT TYPE
- 1.5.2 REST OF WORLD ONYCHOMYCOSIS TREATMENT MARKET, BY DRUG CLASS
- 1.5.3 REST OF WORLD ONYCHOMYCOSIS TREATMENT MARKET, BY COUNTRY
- 1.5.3.1 Brazil
- 1.5.3.1.1 Brazil Onychomycosis Treatment Market, By Treatment type
- 1.5.3.1.2 Brazil Onychomycosis Treatment Market, By Drug Class
- 1.5.3.2 South Africa
- 1.5.3.2.1 South Africa Onychomycosis Treatment Market, By Treatment type
- 1.5.3.2.2 South Africa Onychomycosis Treatment Market, By Drug Class
- 1.5.3.3 GCC
- 1.5.3.3.1 GCC Onychomycosis Treatment Market, By Treatment type
- 1.5.3.3.2 GCC Onychomycosis Treatment Market, By Drug Class
- 1.5.3.4 RoW Countries
- 1.5.3.4.1 RoW Countries Onychomycosis Treatment Market, By Treatment type
- 1.5.3.4.2 RoW Countries Onychomycosis Treatment Market, By Drug Class
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook